Vimarsana
Biggest News Aggregation in the World

Page 8 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based 'Clinical Trial in a Dish' for Alzheimer's Disease - Vimarsana News

Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based 'Clinical Trial in a Dish' for Alzheimer's Disease

Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell

Skye Bioscience, Inc.: Skye Bioscience Receives Positive Safety Review of Fifth Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion - Vimarsana News

Skye Bioscience, Inc.: Skye Bioscience Receives Positive Safety Review of Fifth Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion

Skye plans to complete enrollment of Phase 1 study in June San Diego, California--(Newsfile Corp. - June 2, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company

Satellos Bioscience: Q1 Earnings Snapshot - Vimarsana News

Satellos Bioscience: Q1 Earnings Snapshot

TORONTO — TORONTO — Satellos Bioscience Inc. on Tuesday reported a loss of $1.2 million in its first quarter. On a per-share basis, the Toronto-based company said it had a loss of... | May 30, 2023

Satellos Bioscience Inc.: Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights

- $55 million equity financing closed- Resourced to advance lead drug candidate into clinical trialsToronto, Ontario--(Newsfile Corp. - May 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos"

Twist Bioscience to Present at Upcoming Investor Conferences - Vimarsana News

Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D.,... | May 24, 2023